Ryanodine receptor studies using genetically engineered mice

FEBS Letters

Volumn 584, Issue 10, 2010, Pages 1956-1965

  Kushnir, Alexander ^a   Betzenhauser, Matthew J ^a   Marks, Andrew R ^a,b  

^a Clyde and Helen Wu Center for Molecular Cardiology   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Calstabin2; Excitation contraction coupling; Ryanodine receptor; Transgenic mice

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CALSEQUESTRIN; CARDIOVASCULAR AGENT; RYANODINE RECEPTOR; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 2; RYANODINE RECEPTOR 3; S 107; UNCLASSIFIED DRUG;

ARRHYTHMOGENESIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; DRUG MECHANISM; ENZYME PHOSPHORYLATION; EPILEPSY; EPILEPTOGENESIS; EXCITATION CONTRACTION COUPLING; EXPERIMENTAL MOUSE; GENE FUNCTION; GENE LOCATION; GENE MUTATION; GENETIC ENGINEERING; GENETIC SUSCEPTIBILITY; GLUCOSE METABOLISM; HEART DEATH; HEART FAILURE; HEART PROTECTION; HEART RIGHT VENTRICLE DYSPLASIA; HEAT STROKE; HUMAN; INSULIN RELEASE; LONG TERM POTENTIATION; MALIGNANT HYPERTHERMIA; MUSCLE CONTRACTION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SMOOTH MUSCLE CONTRACTILITY; SUDDEN DEATH;

ANIMALS; BRAIN; HUMANS; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCLE, SMOOTH; MYOCARDIUM; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

MUS; MUS MUSCULUS;

EID: 77952670574     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.03.005     Document Type: Review

References (116)

1. Takeshima H., Iino M., Takekura H., Nishi M., Kuno J., Minowa O., Takano H., Noda T. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 1994, 369:556-559.
2. Takeshima H., Komazaki S., Hirose K., Nishi M., Noda T., Iino M. Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2. EMBO J. 1998, 17:3309-3316.
3. Fill M., Copello J.A. Ryanodine receptor calcium release channels. Physiol. Rev. 2002, 82:893-922.
4. Takeshima H., Yamazawa T., Ikemoto T., Takekura H., Nishi M., Noda T., Iino M. Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. EMBO J. 1995, 14:2999-3006.
5. Giannini G., Conti A., Mammarella S., Scrobogna M., Sorrentino V. The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J. Cell Biol. 1995, 128:893-904.
6. Balschun D., Wolfer D.P., Bertocchini F., Barone V., Conti A., Zuschratter W., Missiaen L., Lipp H.P., Frey J.U., Sorrentino V. Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning. EMBO J. 1999, 18:5264-5273.
7. Noguchi N., Yoshikawa T., Ikeda T., Takahashi I., Shervani N.J., Uruno A., Yamauchi A., Nata K., Takasawa S., Okamoto H., Sugawara A. FKBP12.6 disruption impairs glucose-induced insulin secretion. Biochem. Biophys. Res. Commun. 2008, 371:735-740.
8. Hakamata Y., Nishimura S., Nakai J., Nakashima Y., Kita T., Imoto K. Involvement of the brain type of ryanodine receptor in T-cell proliferation. FEBS Lett. 1994, 352:206-210.
9. Stolk M., Leon-Ponte M., Merrill M., Ahern G.P., O'Connell P.J. IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. J. Leukoc. Biol. 2006, 80:651-658.
10. Neylon C.B., Richards S.M., Larsen M.A., Agrotis A., Bobik A. Multiple types of ryanodine receptor/Ca2+ release channels are expressed in vascular smooth muscle. Biochem. Biophys. Res. Commun. 1995, 215:814-821.
11. Marks A.R., Tempst P., Hwang K.S., Taubman M.B., Inui M., Chadwick C., Fleischer S., Nadal-Ginard B. Molecular cloning and characterization of the ryanodine receptor/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum. Proc. Natl. Acad. Sci. USA 1989, 86:8683-8687.
12. Takeshima H., Nishimura S., Matsumoto T., Ishida H., Kangawa K., Minamino N., Matsuo H., Ueda M., Hanaoka M., Hirose T., Numa S. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 1989, 339:439-445.
13. Zorzato F., Fujii J., Otsu K., Phillips M., Green N.M., Lai F.A., Meissner G., MacLennan D.H. Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 1990, 265:2244-2256.
14. Nakai J., Imagawa T., Hakamat Y., Shigekawa M., Takeshima H., Numa S. Primary structure and functional expression from cDNA of the cardiac ryanodine receptor/calcium release channel. FEBS Lett. 1990, 271:169-177.
15. Otsu K., Willard H.F., Khanna V.K., Zorzato F., Green N.M., MacLennan D.H. Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J. Biol. Chem. 1990, 265:13472-13483.
16. Hakamata Y., Nakai J., Takeshima H., Imoto K. Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain. FEBS Lett. 1992, 312:229-235.
17. Zalk R., Lehnart S.E., Marks A.R. Modulation of the ryanodine receptor and intracellular calcium. Annu. Rev. Biochem. 2007, 76:367-385.
18. Bhat M.B., Zhao J., Takeshima H., Ma J. Functional calcium release channel formed by the carboxyl-terminal portion of ryanodine receptor. Biophys. J. 1997, 73:1329-1336.
19. Du G.G., Sandhu B., Khanna V.K., Guo X.H., MacLennan D.H. Topology of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1). Proc. Natl. Acad. Sci. USA 2002, 99:16725-16730.
20. Proenza C., O'Brien J., Nakai J., Mukherjee S., Allen P.D., Beam K.G. Identification of a region of RyR1 that participates in allosteric coupling with the alpha(1S) (Ca(V)1.1) II-III loop. J. Biol. Chem. 2002, 277:6530-6535.
21. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
22. Bezprozvanny I., Watras J., Ehrlich B.E. Bell-shaped calcium-response curves of Ins(1, 4, 5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 1991, 351:751-754.
23. Fabiato A. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J. Gen. Physiol. 1985, 85:247-289.
24. Laver D.R., Baynes T.M., Dulhunty A.F. Magnesium inhibition of ryanodine-receptor calcium channels: evidence for two independent mechanisms. J. Membr. Biol. 1997, 156:213-229.
25. Meissner G., Darling E., Eveleth J. Kinetics of rapid Ca2+ release by sarcoplasmic reticulum. Effects of Ca2+, Mg2+, and adenine nucleotides. Biochemistry 1986, 25:236-244.
26. Porter Moore C., Zhang J.Z., Hamilton S.L. A role for cysteine 3635 of RYR1 in redox modulation and calmodulin binding. J. Biol. Chem. 1999, 274:36831-36834.
27. Yamaguchi N., Takahashi N., Xu L., Smithies O., Meissner G. Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel. J. Clin. Invest. 2007, 117:1344-1353.
28. Tripathy A., Xu L., Mann G., Meissner G. Calmodulin activation and inhibition of skeletal muscle Ca2+ release channel (ryanodine receptor). Biophys. J. 1995, 69:106-119.
29. Meissner G., Henderson J.S. Rapid calcium release from cardiac sarcoplasmic reticulum vesicles is dependent on Ca2+ and is modulated by Mg2+, adenine nucleotide, and calmodulin. J. Biol. Chem. 1987, 262:3065-3073.
30. Marx S.O., Reiken S., Hisamatsu Y., Gaburjakova M., Gaburjakova J., Yang Y.M., Rosemblit N., Marks A.R. Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine/isoleucine zippers. J. Cell. Biol. 2001, 153:699-708.
31. Brillantes A.B., Ondrias K., Scott A., Kobrinsky E., Ondriasova E., Moschella M.C., Jayaraman T., Landers M., Ehrlich B.E., Marks A.R. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 1994, 77:513-523.
32. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000, 101:365-376.
33. Marx S.O., Gaburjakova J., Gaburjakova M., Henrikson C., Ondrias K., Marks A.R. Coupled gating between cardiac calcium release channels (ryanodine receptors). Circ. Res. 2001, 88:1151-1158.
34. Chelu M.G., Danila C.I., Gilman C.P., Hamilton S.L. Regulation of ryanodine receptors by FK506 binding proteins. Trends Cardiovasc. Med. 2004, 14:227-234.
35. Wehrens X.H., Marks A.R. Altered function and regulation of cardiac ryanodine receptors in cardiac disease. Trends Biochem. Sci. 2003, 28:671-678.
36. Witcher D.R., Kovacs R.J., Schulman H., Cefali D.C., Jones L.R. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J. Biol. Chem. 1991, 266:11144-11152.
37. Mayrleitner M., Chandler R., Schindler H., Fleischer S. Phosphorylation with protein kinases modulates calcium loading of terminal cisternae of sarcoplasmic reticulum from skeletal muscle. Cell Calcium 1995, 18:197-206.
38. Gyorke S., Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovasc. Res. 2008, 77:245-255.
39. Chopra N., Yang T., Asghari P., Moore E.D., Huke S., Akin B., Cattolica R.A., Perez C.F., Hlaing T., Knollmann-Ritschel B.E., Jones L.R., Pessah I.N., Allen P.D., Franzini-Armstrong C., Knollmann B.C. Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc. Natl. Acad. Sci. USA 2009, 106:7636-7641.
40. Oddoux S., Brocard J., Schweitzer A., Szentesi P., Giannesini B., Faure J., Pernet-Gallay K., Bendahan D., Lunardi J., Csernoch L., Marty I. Triadin deletion induces impaired skeletal muscle function. J. Biol. Chem. 2009, 284:34918-34929.
41. Yuan Q., Fan G.C., Dong M., Altschafl B., Diwan A., Ren X., Hahn H.H., Zhao W., Waggoner J.R., Jones L.R., Jones W.K., Bers D.M., Dorn G.W., Wang H.S., Valdivia H.H., Chu G., Kranias E.G. Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity. Circulation 2007, 115:300-309.
42. Farrell E.F., Antaramian A., Benkusky N., Zhu X., Rueda A., Gomez A.M., Valdivia H.H. Regulation of cardiac excitation-contraction coupling by sorcin, a novel modulator of ryanodine receptors. Biol. Res. 2004, 37:609-612.
43. Sutko J.L., Ito K., Kenyon J.L. Ryanodine: a modifier of sarcoplasmic reticulum calcium release in striated muscle. Fed. Proc. 1985, 44:2984-2988.
44. Ikemoto T., Komazaki S., Takeshima H., Nishi M., Noda T., Iino M., Endo M. Functional and morphological features of skeletal muscle from mutant mice lacking both type 1 and type 3 ryanodine receptors. J. Physiol. 1997, 501(Pt 2):305-312.
45. Barone V., Bertocchini F., Bottinelli R., Protasi F., Allen P.D., Franzini Armstrong C., Reggiani C., Sorrentino V. Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors. FEBS Lett. 1998, 422:160-164.
46. Rossi R., Bottinelli R., Sorrentino V., Reggiani C. Response to caffeine and ryanodine receptor isoforms in mouse skeletal muscles. Am. J. Physiol. Cell Physiol. 2001, 281:C585-C594.
47. Bertocchini F., Ovitt C.E., Conti A., Barone V., Scholer H.R., Bottinelli R., Reggiani C., Sorrentino V. Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles. EMBO J. 1997, 16:6956-6963.
48. Takekura H., Nishi M., Noda T., Takeshima H., Franzini-Armstrong C. Abnormal junctions between surface membrane and sarcoplasmic reticulum in skeletal muscle with a mutation targeted to the ryanodine receptor. Proc. Natl. Acad. Sci. USA 1995, 92:3381-3385.
49. Nakai J., Dirksen R.T., Nguyen H.T., Pessah I.N., Beam K.G., Allen P.D. Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 1996, 380:72-75.
50. Bellinger A.M., Mongillo M., Marks A.R. Stressed out: the skeletal muscle ryanodine receptor as a target of stress. J. Clin. Invest. 2008, 118:445-453.
51. O'Connell K.M., Yamaguchi N., Meissner G., Dirksen R.T. Calmodulin binding to the 3614-3643 region of RyR1 is not essential for excitation-contraction coupling in skeletal myotubes. J. Gen. Physiol. 2002, 120:337-347.
52. Avila G., Dirksen R.T. Functional impact of the ryanodine receptor on the skeletal muscle L-type Ca(2+) channel. J. Gen. Physiol. 2000, 115:467-480.
53. Grabner M., Dirksen R.T., Suda N., Beam K.G. The II-III loop of the skeletal muscle dihydropyridine receptor is responsible for the bi-directional coupling with the ryanodine receptor. J. Biol. Chem. 1999, 274:21913-21919.
54. Chelu M.G., Goonasekera S.A., Durham W.J., Tang W., Lueck J.D., Riehl J., Pessah I.N., Zhang P., Bhattacharjee M.B., Dirksen R.T., Hamilton S.L. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J. 2006, 20:329-330.
55. Durham W.J., Aracena-Parks P., Long C., Rossi A.E., Goonasekera S.A., Boncompagni S., Galvan D.L., Gilman C.P., Baker M.R., Shirokova N., Protasi F., Dirksen R., Hamilton S.L. RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell 2008, 133:53-65.
56. Yang T., Riehl J., Esteve E., Matthaei K.I., Goth S., Allen P.D., Pessah I.N., Lopez J.R. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology 2006, 105:1164-1175.
57. Zvaritch E., Depreux F., Kraeva N., Loy R.E., Goonasekera S.A., Boncompagni S., Kraev A., Gramolini A.O., Dirksen R.T., Franzini-Armstrong C., Seidman C.E., Seidman J.G., Maclennan D.H. An Ryr1I4895T mutation abolishes Ca2+ release channel function and delays development in homozygous offspring of a mutant mouse line. Proc. Natl. Acad. Sci. USA 2007, 104:18537-18542.
58. Hillyard I., Procia L. Action of ryanodine on isolated kitten auricle. Fed. Proc. 1956, 15:438.
59. Meissner G. Ryanodine activation and inhibition of the Ca2+ release channel of sarcoplasmic reticulum. J. Biol. Chem. 1986, 261:6300-6306.
60. Luo W., Chu G., Sato Y., Zhou Z., Kadambi V.J., Kranias E.G. Transgenic approaches to define the functional role of dual site phospholamban phosphorylation. J. Biol. Chem. 1998, 273:4734-4739.
61. MacDonnell S.M., Garcia-Rivas G., Scherman J.A., Kubo H., Chen X., Valdivia H., Houser S.R. Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808. Circ. Res. 2008, 102:e65-e72.
62. Benkusky N.A., Weber C.S., Scherman J.A., Farrell E.F., Hacker T.A., John M.C., Powers P.A., Valdivia H.H. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circ. Res. 2007, 101:819-829.
63. Zhou P., Zhao Y.T., Guo Y.B., Xu S.M., Bai S.H., Lakatta E.G., Cheng H., Hao X.M., Wang S.Q. Beta-adrenergic signaling accelerates and synchronizes cardiac ryanodine receptor response to a single L-type Ca2+ channel. Proc. Natl. Acad. Sci. USA 2009, 106:18028-18033.
64. Lindegger N., Niggli E. Paradoxical SR Ca2+ release in guinea-pig cardiac myocytes after beta-adrenergic stimulation revealed by two-photon photolysis of caged Ca2+. J. Physiol. 2005, 565:801-813.
65. Lehnart S., Marks A.R. Regulation of ryanodine receptors in the heart. Circ. Res. 2007, 101:746-749.
66. Wehrens X.H., Lehnart S.E., Reiken S., Vest J.A., Wronska A., Marks A.R. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc. Natl. Acad. Sci. USA 2006, 103:511-518.
67. Xiao B., Jiang M.T., Zhao M., Yang D., Sutherland C., Lai F.A., Walsh M.P., Warltier D.C., Cheng H., Chen S.R. Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure. Circ. Res. 2005, 96:847-855.
68. Huke S., Bers D.M. Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochem. Biophys. Res. Commun. 2008, 376:80-85.
69. Chelu M.G., Sarma S., Sood S., Wang S., van Oort R.J., Skapura D.G., Li N., Santonastasi M., Muller F.U., Schmitz W., Schotten U., Anderson M.E., Valderrabano M., Dobrev D., Wehrens X.H. Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J. Clin. Invest. 2009, 119:1940-1951.
70. Wehrens X.H., Lehnart S.E., Reiken S.R., Marks A.R. Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ. Res. 2004, 94:e61-e70.
71. Wehrens X.H., Lehnart S.E., Huang F., Vest J.A., Reiken S.R., Mohler P.J., Sun J., Guatimosim S., Song L.S., Rosemblit N., D'Armiento J.M., Napolitano C., Memmi M., Priori S.G., Lederer W.J., Marks A.R. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 2003, 113:829-840.
72. Wehrens X.H., Lehnart S.E., Reiken S., van der Nagel R., Morales R., Sun J., Cheng Z., Deng S.X., de Windt L.J., Landry D.W., Marks A.R. Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proc. Natl. Acad. Sci. USA 2005, 102:9607-9612.
73. Lehnart S.E., Terrenoire C., Reiken S., Wehrens X.H., Song L.S., Tillman E.J., Mancarella S., Coromilas J., Lederer W.J., Kass R.S., Marks A.R. Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. Proc. Natl. Acad. Sci. USA 2006, 103:7906-7910.
74. Xiao J., Tian X., Jones P.P., Bolstad J., Kong H., Wang R., Zhang L., Duff H.J., Gillis A.M., Fleischer S., Kotlikoff M., Copello J.A., Chen S.R. Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias. J. Biol. Chem. 2007, 282:34828-34838.
75. Danila C.I., Hamilton S.L. Phosphorylation of ryanodine receptors. Biol. Res. 2004, 37:521-525.
76. Xiao B., Sutherland C., Walsh M.P., Chen S.R. Protein kinase A phosphorylation at serine-2808 of the cardiac Ca2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6). Circ. Res. 2004, 94:487-495.
77. Aracena P., Tang W., Hamilton S.L., Hidalgo C. Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels. Antioxid. Redox Signal. 2005, 7:870-881.
78. Bellinger A.M., Reiken S., Carlson C., Mongillo M., Liu X., Rothman L., Matecki S., Lacampagne A., Marks A.R. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat. Med. 2009, 15:325-330.
79. Zissimopoulos S., Docrat N., Lai F.A. Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein. J. Biol. Chem. 2007, 282:6976-6983.
80. Yano M., Okuda S., Oda T., Tokuhisa T., Tateishi H., Mochizuki M., Noma T., Doi M., Kobayashi S., Yamamoto T., Ikeda Y., Ohkusa T., Ikemoto N., Matsuzaki M. Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure. Circulation 2005, 112:3633-3643.
81. Sood S., Chelu M.G., van Oort R.J., Skapura D., Santonastasi M., Dobrev D., Wehrens X.H. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm 2008, 5:1047-1054.
82. Loughrey C.M., Otani N., Seidler T., Craig M.A., Matsuda R., Kaneko N., Smith G.L. K201 modulates excitation-contraction coupling and spontaneous Ca2+ release in normal adult rabbit ventricular cardiomyocytes. Cardiovasc. Res. 2007, 76:236-246.
83. Wehrens X.H., Lehnart S.E., Reiken S.R., Deng S.X., Vest J.A., Cervantes D., Coromilas J., Landry D.W., Marks A.R. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 2004, 304:292-296.
84. Xin H.B., Senbonmatsu T., Cheng D.S., Wang Y.X., Copello J.A., Ji G.J., Collier M.L., Deng K.Y., Jeyakumar L.H., Magnuson M.A., Inagami T., Kotlikoff M.I., Fleischer S. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 2002, 416:334-338.
85. Zhang Y., Huang Z.J., Dai D.Z., Feng Y., Na T., Tang X.Y., Dai Y. Downregulated FKBP12.6 expression and upregulated endothelin signaling contribute to elevated diastolic calcium and arrhythmogenesis in rat cardiomyopathy produced by l-thyroxin. Int. J. Cardiol. 2008, 130:463-471.
86. Gellen B., Fernandez-Velasco M., Briec F., Vinet L., LeQuang K., Rouet-Benzineb P., Benitah J.P., Pezet M., Palais G., Pellegrin N., Zhang A., Perrier R., Escoubet B., Marniquet X., Richard S., Jaisser F., Gomez A.M., Charpentier F., Mercadier J.J. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation 2008, 117:1778-1786.
87. Liu N., Colombi B., Memmi M., Zissimopoulos S., Rizzi N., Negri S., Imbriani M., Napolitano C., Lai F.A., Priori S.G. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ. Res. 2006, 99:292-298.
88. Zhang T., Maier L.S., Dalton N.D., Miyamoto S., Ross J., Bers D.M., Brown J.H. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 2003, 92:912-919.
89. Ling H., Zhang T., Pereira L., Means C.K., Cheng H., Gu Y., Dalton N.D., Peterson K.L., Chen J., Bers D., Heller Brown J. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J. Clin. Invest. 2009, 119:1230-1240.
90. Lehnart S.E., Mongillo M., Bellinger A., Lindegger N., Chen B.X., Hsueh W., Reiken S., Wronska A., Drew L.J., Ward C.W., Lederer W.J., Kass R.S., Morley G., Marks A.R. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J. Clin. Invest. 2008, 118:2230-2245.
91. Fernandez-Velasco M., Rueda A., Rizzi N., Benitah J.P., Colombi B., Napolitano C., Priori S.G., Richard S., Gomez A.M. Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia. Circ. Res. 2009, 104:201-209. (12p following 209).
92. Jiang D., Xiao B., Yang D., Wang R., Choi P., Zhang L., Cheng H., Chen S.R. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc. Natl. Acad. Sci. USA 2004, 101:13062-13067.
93. Cerrone M., Noujaim S.F., Tolkacheva E.G., Talkachou A., O'Connell R., Berenfeld O., Anumonwo J., Pandit S.V., Vikstrom K., Napolitano C., Priori S.G., Jalife J. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ. Res. 2007, 101:1039-1048.
94. Goddard C.A., Ghais N.S., Zhang Y., Williams A.J., Colledge W.H., Grace A.A., Huang C.L. Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts. Acta Physiol. (Oxf.) 2008, 194:123-140.
95. George C.H., Jundi H., Walters N., Thomas N.L., West R.R., Lai F.A. Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction. Circ. Res. 2006, 98:88-97.
96. Tateishi H., Yano M., Mochizuki M., Suetomi T., Ono M., Xu X., Uchinoumi H., Okuda S., Oda T., Kobayashi S., Yamamoto T., Ikeda Y., Ohkusa T., Ikemoto N., Matsuzaki M. Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts. Cardiovasc. Res. 2009, 81:536-545.
97. Kannankeril P.J., Mitchell B.M., Goonasekera S.A., Chelu M.G., Zhang W., Sood S., Kearney D.L., Danila C.I., De Biasi M., Wehrens X.H., Pautler R.G., Roden D.M., Taffet G.E., Dirksen R.T., Anderson M.E., Hamilton S.L. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc. Natl. Acad. Sci. USA 2006, 103:12179-12184.
98. Rizzi N., Liu N., Napolitano C., Nori A., Turcato F., Colombi B., Bicciato S., Arcelli D., Spedito A., Scelsi M., Villani L., Esposito G., Boncompagni S., Protasi F., Volpe P., Priori S.G. Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model. Circ. Res. 2008, 103:298-306.
99. Song L., Alcalai R., Arad M., Wolf C.M., Toka O., Conner D.A., Berul C.I., Eldar M., Seidman C.E., Seidman J.G. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J. Clin. Invest. 2007, 117:1814-1823.
100. Postma A.V., Denjoy I., Hoorntje T.M., Lupoglazoff J.M., Da Costa A., Sebillon P., Mannens M.M., Wilde A.A., Guicheney P. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ. Res. 2002, 91:e21-e26.
101. Knollmann B.C., Chopra N., Hlaing T., Akin B., Yang T., Ettensohn K., Knollmann B.E., Horton K.D., Weissman N.J., Holinstat I., Zhang W., Roden D.M., Jones L.R., Franzini-Armstrong C., Pfeifer K. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J. Clin. Invest. 2006, 116:2510-2520.
102. Yang H.T., Tweedie D., Wang S., Guia A., Vinogradova T., Bogdanov K., Allen P.D., Stern M.D., Lakatta E.G., Boheler K.R. The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development. Proc. Natl. Acad. Sci. USA 2002, 99:9225-9230.
103. Wu Y., Gao Z., Chen B., Koval O.M., Singh M.V., Guan X., Hund T.J., Kutschke W., Sarma S., Grumbach I.M., Wehrens X.H., Mohler P.J., Song L.S., Anderson M.E. Calmodulin kinase II is required for fight or flight sinoatrial node physiology. Proc. Natl. Acad. Sci. USA 2009, 106:5972-5977.
104. Takeshima H., Ikemoto T., Nishi M., Nishiyama N., Shimuta M., Sugitani Y., Kuno J., Saito I., Saito H., Endo M., Iino M., Noda T. Generation and characterization of mutant mice lacking ryanodine receptor type 3. J. Biol. Chem. 1996, 271:19649-19652.
105. Matsuo N., Tanda K., Nakanishi K., Yamasaki N., Toyama K., Takao K., Takeshima H., Miyakawa T. Comprehensive behavioral phenotyping of ryanodine receptor type 3 (RyR3) knockout mice. Decreased social contact duration in two social interaction tests. Front. Behav. Neurosci. 2009, 3:3.
106. Wan K., Moriya T., Akiyama M., Takeshima H., Shibata S. Involvement of ryanodine receptor type 3 in dopamine release from the striatum: evidence from mutant mice lacking this receptor. Biochem. Biophys. Res. Commun. 1999, 266:588-592.
107. Shimuta M., Yoshikawa M., Fukaya M., Watanabe M., Takeshima H., Manabe T. Postsynaptic modulation of AMPA receptor-mediated synaptic responses and LTP by the type 3 ryanodine receptor. Mol. Cell Neurosci. 2001, 17:921-930.
108. Futatsugi A., Kato K., Ogura H., Li S.T., Nagata E., Kuwajima G., Tanaka K., Itohara S., Mikoshiba K. Facilitation of NMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3. Neuron 1999, 24:701-713.
109. Kouzu Y., Moriya T., Takeshima H., Yoshioka T., Shibata S. Mutant mice lacking ryanodine receptor type 3 exhibit deficits of contextual fear conditioning and activation of calcium/calmodulin-dependent protein kinase II in the hippocampus. Brain Res. Mol. Brain Res. 2000, 76:142-150.
110. Matyash M., Matyash V., Nolte C., Sorrentino V., Kettenmann H. Requirement of functional ryanodine receptor type 3 for astrocyte migration. FASEB J. 2002, 16:84-86.
111. Nelson M.T., Cheng H., Rubart M., Santana L.F., Bonev A.D., Knot H.J., Lederer W.J. Relaxation of arterial smooth muscle by calcium sparks. Science 1995, 270:633-637.
112. Hotta S., Morimura K., Ohya S., Muraki K., Takeshima H., Imaizumi Y. Ryanodine receptor type 2 deficiency changes excitation-contraction coupling and membrane potential in urinary bladder smooth muscle. J. Physiol. 2007, 582:489-506.
113. Liu Q.H., Zheng Y.M., Korde A.S., Yadav V.R., Rathore R., Wess J., Wang Y.X. Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle. Proc. Natl. Acad. Sci. USA 2009, 106:11418-11423.
114. Ji G., Feldman M.E., Greene K.S., Sorrentino V., Xin H.B., Kotlikoff M.I. RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle. J. Gen. Physiol. 2004, 123:377-386.
115. Lohn M., Jessner W., Furstenau M., Wellner M., Sorrentino V., Haller H., Luft F.C., Gollasch M. Regulation of calcium sparks and spontaneous transient outward currents by RyR3 in arterial vascular smooth muscle cells. Circ. Res. 2001, 89:1051-1057.
116. Komazaki S., Ikemoto T., Takeshima H., Iino M., Endo M., Nakamura H. Morphological abnormalities of adrenal gland and hypertrophy of liver in mutant mice lacking ryanodine receptors. Cell Tissue Res. 1998, 294:467-473.